Can I Buy Biogen Inc Shares in India?

Yes, Biogen Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy Biogen Inc Shares in India?

One can easily invest in Biogen Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Biogen Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Biogen Inc.

What is the Share Price of Biogen Inc?

The share price of Biogen Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Biogen Inc share price is $150.50 as of 14 Dec ‘24

What is the Market Cap of Biogen Inc?

The Biogen Inc market cap is $21.86B as of 14 Dec ‘24

What is the PE and PB ratio of Biogen Inc?

The PE and PB ratio of Biogen Inc is 13.5 and 1.3 as of 14 Dec ‘24

Biogen Inc Share Price, BIIB Stock Price Quote Today

<img alt="Biogen Inc" srcSet="https://assets-netstorage.groww.in/intl-stocks/logos/BIIB.png 1x, https://assets-netstorage.groww.in/intl-stocks/logos/BIIB.png 2x" src="https://assets-netstorage.groww.in/intl-stocks/logos/BIIB.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
Biogen Inc Healthcare 
$150.50
-4.83(3.11%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$154.57$155.331,608,4731,610,625
FundamentalsMarket Cap$21.86B
P/B Ratio1.3
P/E Ratio13.5
Enterprise Value$26.81B
Div. Yield0.00%
Book Value100.03
EPS(TTM)10.15
ROE10.40%
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyBiogen, Inc. is a multinational biotechnology company that specialises in the treatment of neurological diseases. It discovers, develops, and delivers therapies to treat maladies like multiple sclerosis, Alzheimer’s disease, and spinal muscular atrophy. The company was established in 1978 by several prominent biologists, including Walter Gilbert and Phillip Allen Sharp. Gilbert served as its CEO during the start-up phase and went on to accept a Nobel Prize in Chemistry in 1980. Subsequently, Sharp was awarded the Nobel Prize for Physiology or Medicine in 1993. 
The company is headquartered in Cambridge, Massachusetts, United States. Biogen shares trade on the NASDAQ Stock Exchange under the ticker symbol BIIB. It merged with Idec Pharmaceuticals in a $6.8 billion deal and changed its name to Biogen Idec. With this merger, Biogen Idec became one of the largest biotech companies in the world. However, the company later shortened its name, following shifts in its research areas, and reverted to just Biogen. BIIB stock is a component of several indices, namely the NASDAQ 100, S&P 1500, S&P 500 as well as the S&P 100. 
In 2013, BIIB purchased all rights to Tysabri, a medication for multiple sclerosis, from its partner Elan Pharmaceuticals in a transaction worth $3.25 billion. Over the years, Biogen has expanded its operations through multiple acquisitions. As of 2020, its latest addition to this list is Nightstar Therapeutics in 2019, with a purchase price of approximately $800 million. BIIB operates internationally in the Americas, Europe, and Asia. New Zealand, Japan, Australia, Italy, Germany, China, Belgium, Poland, and South Korea are some of the countries with its corporate offices. In 2020, Forbes included Biogen in its list of Just Companies as well as World’s Best Employers. BIIB ranked 213th on the list of Fortune 500 and 366th on Forbes’ Global 2000 companies.;
OrganisationBiogen Inc
IndustryDrug Manufacturers—General
HeadQuartersCambridge, MA
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Open Price	Prev. Close	Volume	Avg. Volume
$154.57	$155.33	1,608,473	1,610,625

Market Cap	$21.86B
P/B Ratio	1.3
P/E Ratio	13.5
Enterprise Value	$26.81B

Organisation	Biogen Inc
Industry	Drug Manufacturers—General
HeadQuarters	Cambridge, MA